Dantrium Intravenous (Dantrolene sodium for injection):… recall
Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter
- Published
- 19 Oct 2026
- Agency
- Health Canada
- Country
- Canada
The hazard
Contamination
Classification: Type I
What to do
Consult your healthcare provider for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Source: Health Canada, published 19 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.